Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03491826
Other study ID # 123
Secondary ID
Status Completed
Phase
First received March 28, 2018
Last updated April 6, 2018
Start date January 2010
Est. completion date December 2014

Study information

Verified date April 2018
Source Kasr El Aini Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this study is to compare fetal and maternal outcome in cases of PPROM before 34 weeks versus after 34 weeks.


Description:

The data will be retrieved from the archival files and analyzed


Recruitment information / eligibility

Status Completed
Enrollment 1011
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Female
Age group 24 Years to 39 Years
Eligibility Inclusion Criteria:

- rupture of membrane

Exclusion Criteria:

- medical disorder

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
rupture of membrane


Locations

Country Name City State
Egypt Kasr El Ainiy Hospital Cairo

Sponsors (2)

Lead Sponsor Collaborator
sarah mohamed hassan Hend Mostafa Hussein Salem

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary maternal mortality maternal mortality up to 48 hours after delivery
See also
  Status Clinical Trial Phase
Completed NCT04100252 - The Impact of Amniotic Fluid Index (AFI) on Maternal and Perinatal Outcomes in Pregnant Women With Preterm Premature Rupture of Membranes
Recruiting NCT04478942 - PROMMO Trial: Oral Misoprostol vs IV Oxytocin Early Phase 1
Recruiting NCT02819570 - Comparison of Two Antibiotic Prophylactic Protocols in Preterm Premature Rupture of the Membranes Phase 4
Withdrawn NCT03172858 - Randomized Control Trial of Intracervical Balloon Placement vs Oxytocin in Women With Term PROM and Unripe Cervices N/A
Not yet recruiting NCT05134688 - Magnesium Sulphate in Premature Rupture of Membranes Early Phase 1
Not yet recruiting NCT03689062 - Premature Rupture of Membranes at 34 to 37 Weeks' Gestation N/A
Recruiting NCT06273891 - Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes Phase 3
Recruiting NCT04237142 - Preterm Premature Rupture of Fetal Membranes: Cervical Ultrasound and Biological Markers to Diagnose Prematurity (RECHOBIOL) N/A
Recruiting NCT04558996 - Spanish Registry of Pregnant Women With COVID-19
Recruiting NCT04632017 - Computerized Cardiotocography Monitoring of Fetuses With pPROM
Recruiting NCT03607929 - HIDRATA Study: Efficacy of a Hydration Protocol in Nulliparous Women During Labor N/A
Enrolling by invitation NCT04451109 - Dilapan-S®: A Multicenter US E-registry
Recruiting NCT04143685 - Labor Induction With Misoprostol Versus Oxytocin in Women With Premature Rupture of Membranes N/A
Completed NCT03251898 - Correlation Between Premature Rupture of Membranes and Early-onset Neonatal Infections
Completed NCT03106311 - The Use of Quantitative Pregnancy Test in Amniotic Fluid as a Diagnostic Tool for Rupture of Fetal Membranes N/A